Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of Unruptured Small and Medium-Sized Wide Necked Aneurysms Using the 64-Wire Surpass Evolve: A Subanalysis From the SEASE International Registry.
Dibas M, Vivanco-Suarez J, Lopes DK, Hanel RA, Rodriguez-Calienes A, Cortez GM, Fifi JT, Devarajan A, Toth G, Patterson TE, Altschul D, Pereira VM, Liu XYE, Puri AS, Kühn AL, Guerrero WR, Khandelwal P, Bach I, Kan PT, Edhayan G, Martinez-Galdamez M, Given C, Gross BA, Narayanan S, Galecio-Castillo M, Derakhshani S, Ortega-Gutierrez S. Dibas M, et al. Among authors: liu xye. J Am Heart Assoc. 2024 Oct 25:e036365. doi: 10.1161/JAHA.124.036365. Online ahead of print. J Am Heart Assoc. 2024. PMID: 39450745
[Development of a prediction model for the incidence of type 2 diabetic kidney disease and its application based on a regional health data platform].
Liu LJ, Chen XW, Yu YX, Zhang M, Li P, Zhao HY, Sun YX, Sun HY, Sun YM, Liu XY, Lin HB, Shen P, Zhan SY, Sun F. Liu LJ, et al. Among authors: liu xy. Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Oct 10;45(10):1426-1432. doi: 10.3760/cma.j.cn112338-20240117-00024. Zhonghua Liu Xing Bing Xue Za Zhi. 2024. PMID: 39444128 Chinese.
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
He M, Jiang YZ, Gong Y, Fan L, Liu XY, Liu Y, Tang LC, Mo M, Hou YF, Di GH, Liu GY, Yu KD, Wu J, Yan X, Zeng XH, Fu DY, Song CG, Zhuang ZG, Wu KJ, Wang J, Wang ZH, Shao ZM. He M, et al. Among authors: liu xy. BMJ. 2024 Oct 23;387:e079603. doi: 10.1136/bmj-2024-079603. BMJ. 2024. PMID: 39442958 Free PMC article. Clinical Trial.
4,044 results